MedTrace Logo

The Brugada Syndrome: a Follow-up Study

NCT03485508 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2018-04-02

No results posted yet for this study

Summary

Although for many years the Brugada syndrome has been labelled as a purely electrical disease in the structurally normal heart, the evolution of imaging techniques has enabled the discovery of subtle morphofunctional alterations in some of the Brugada syndrome patients. We will use new echocardiographic techniques to assess cardiac function in these patients and new parameters will be evaluated for their prognostic value as risk stratificators.

Conditions

  • Brugada Syndrome

Interventions

DIAGNOSTIC_TEST

Transthoracic echocardiography

Transthoracic echocardiography Blood sample with assessment of biomarkers

Sponsors & Collaborators

  • Universitair Ziekenhuis Brussel

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-03-11
Primary Completion
2018-09-30
Completion
2019-07-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03485508 on ClinicalTrials.gov